Please login to the form below

Not currently logged in
Email:
Password:

MHRA

This page shows the latest MHRA news and features for those working in and with pharma, biotech and healthcare.

Alternatives to AZ vaccine should be offered to those under 30 in the UK

Alternatives to AZ vaccine should be offered to those under 30 in the UK

The Medicines and Healthcare products Regulatory Agency (MHRA) has said that cases of blood clots after having the AZ/Oxford vaccine are extremely rare. ... The MHRA also confirmed that those due for a second dose of the AZ/Oxford vaccine.

Latest news

More from news
Approximately 40 fully matching, plus 259 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    The MHRA meets the standards of the EMA, PDMA and FDA, but it also encourages innovation through its openness, advice and support services for partners. ... Lastly, to international audiences, we need to continue to highlight the leading work of the MHRA

  • A cultural shift in clinical research A cultural shift in clinical research

    Since 2018, the MHRA has allowed the use of electronic methods for seeking, confirming and documenting informed consent for participation in research.

  • Integrating electronic health records into clinical trials Integrating electronic health records into clinical trials

    MHRA has encountered EHR systems that prevent internal and external monitors from accessing the data, leading researchers to print out records. ... MHRA is also working to resolve the problems it encounters when inspecting studies that use EHRs.

  • The evolution of real-world studies The evolution of real-world studies

    The UK has high hopes for the study, which the Medicines and Healthcare products Regulatory Agency (MHRA) thinks is “the first large commercial real-world pragmatic trial of its type using ... The MHRA hopes the trial will “attract global

  • “Brexit has been a catalyst for UK clinical research... it’s turbocharged change” “Brexit has been a catalyst for UK clinical research... it’s turbocharged change”

    National Institute for Health Research (NIHR) and the UK’s medicines regulator the MHRA. ... likely). While the government, the MHRA, UK pharma and all the stakeholders have made preparations for this eventuality, all are hoping that a no-deal scenario

More from intelligence
Approximately 2 fully matching, plus 26 partially matching documents found.

Latest appointments

More from appointments
Approximately 11 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....
How to tell your healthcare story.
Healthcare research is not a simple story and the people in charge of those moments need to be careful about the story that they tell....

Infographics